Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
A Clinical Study to Assess the Safety of PEG-Hirudin (SPP200) Compared to Heparin in Patients Who Are on Haemodialysis
This study has been completed.
Study NCT00074620. Last updated on October 4, 2007.
Information provided by Speedel Pharma Ltd.
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chronic Kidney Failure
Vascular Graft Occlusion
Additional conditions recognized in this trial
Graft Occlusion, Vascular
Kidney Failure
Kidney Failure, Chronic
More general conditions related to this trial
Kidney Diseases
Pathologic Processes
Postoperative Complications
Renal Insufficiency
Renal Insufficiency, Chronic
Urologic Diseases
Interventions listed in this trial
PEG-hirudin
Additional drug interventions recognized in this trial
Hirudins
More general drug interventions related to this trial
Cardiovascular Agents
Enzyme Inhibitors
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protease Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Speedel Pharma Ltd.
Quintiles
Back to top of Main Content